These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 575093)

  • 21. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of phencyclidine on amphetamine stereotypy in rats.
    Balster RL; Chait LD
    Eur J Pharmacol; 1978 Apr; 48(4):445-50. PubMed ID: 565717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats.
    Sams-Dodd F
    Neuropsychopharmacology; 1998 Jul; 19(1):18-25. PubMed ID: 9608573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.
    Tanii Y; Nishikawa T; Hashimoto A; Takahashi K
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions.
    Contreras PC; Rice KC; Jacobson AE; O'Donohue TL
    Eur J Pharmacol; 1986 Feb; 121(1):9-18. PubMed ID: 3007170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates.
    French ED
    Neuropharmacology; 1988 Aug; 27(8):791-8. PubMed ID: 3216958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticonvulsant and behavioral effects of phencyclidine and ketamine following chronic treatment in rats.
    Leccese AP; Marquis KL; Mattia A; Moreton JE
    Behav Brain Res; 1986 Dec; 22(3):257-64. PubMed ID: 3790247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
    Gray NM; Cheng BK; Mick SJ; Lair CM; Contreras PC
    J Med Chem; 1989 Jun; 32(6):1242-8. PubMed ID: 2542555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
    Nabeshima T; Hiramatsu M; Kameyama T
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase.
    Bird DC; Bujas-Bobanovic M; Robertson HA; Dursun SM
    Psychopharmacology (Berl); 2001 May; 155(3):299-309. PubMed ID: 11432693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
    Valentine JL; Mayersohn M; Wessinger WD; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):709-16. PubMed ID: 8768722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.
    Nabeshima T; Yamada K; Yamaguchi K; Hiramatsu M; Furukawa H; Kameyama T
    Eur J Pharmacol; 1983 Aug; 91(4):455-62. PubMed ID: 6684578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.
    Greenberg BD; Segal DS
    Pharmacol Biochem Behav; 1985 Jul; 23(1):99-105. PubMed ID: 4041046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phencyclidine-induced stereotyped behavior and serotonergic syndrome in rat.
    Martin JR; Berman MH; Krewsun I; Small SF
    Life Sci; 1979 Apr; 24(18):1699-703. PubMed ID: 573357
    [No Abstract]   [Full Text] [Related]  

  • 35. The ontogeny of behavioral sensitization to phencyclidine.
    Scalzo FM; Holson RR
    Neurotoxicol Teratol; 1992; 14(1):7-14. PubMed ID: 1593982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of phencyclidine and its major metabolite, (trans)4-phenyl-4-(1-piperidinyl)cyclohexanol, in mice.
    Baba A; Yamamoto T; Kawai N; Yamamoto H; Suzuki T; Moroji T
    Behav Brain Res; 1994 Nov; 65(1):75-81. PubMed ID: 7880457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of the involvement of D1 dopamine receptors in PCP-induced stereotypy and ataxia in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Pharmacol Res; 1990; 22(2):197-205. PubMed ID: 2184422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
    Hiramatsu M; Nabeshima T; Fukaya H; Furukawa H; Kameyama T
    Eur J Pharmacol; 1986 Jan; 120(1):69-74. PubMed ID: 3456306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prenatal phencyclidine on 3H-PCP binding and PCP-induced motor activity and ataxia.
    Fico TA; Vanderwende C
    Neurotoxicol Teratol; 1989; 11(4):373-6. PubMed ID: 2796892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ontogeny of phencyclidine-induced wall climbing and locomotor activity.
    Scalzo FM; Burge LJ
    Dev Psychobiol; 1992 Dec; 25(8):597-612. PubMed ID: 1487084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.